查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1905024

全球生技设备市场（按产品、最终用途和地区划分）—市场规模、产业趋势、机会分析和预测（2026-2035 年）

Global Biotechnology Instruments Market: By Product, By End-use, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 240 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

生技设备市场目前正经历强劲成长，反映出生物技术在医疗、研究和工业应用中日益重要的角色。 2025 年，该市场规模为 921.2 亿美元，预计到 2035 年将达到 1,417 亿美元。这一预测成长意味着 2026 年至 2035 年预测期内的复合年增长率 (CAGR) 为 4.4%，表明未来十年将保持稳定持续成长。对先进生物技术设备的需求不断增长是推动市场成长的关键因素；这些设备对于在多个领域进行尖端研发至关重要。

推动市场成长的关键因素很多。其中一个主要驱动因素是专注于个人化医疗的研发活动激增，个人化医疗根据个人的基因谱量身订做治疗方案。基因组学及相关技术的日益普及需要能够进行高通量和精确分析的先进仪器，从而推动了整个生物技术设备产业的需求。此外，全球慢性病盛行率的上升也促使人们需要改善诊断和治疗方案，进而刺激了对生物技术研究的投入。

市场趋势

生技设备市场正经历显着的整合，赛默飞世尔科技（Thermo Fisher Scientific）和丹纳赫公司（Danaher Corporation）等产业巨头占了市场主导地位。这些公司凭藉涵盖广泛生命科学领域的多元化产品组合保持优势。成熟的全球网络、强大的研发能力和全面的服务巩固了它们的市场领导地位。

儘管市场集中度较高，但专注于特定细分领域的颠覆性创新仍使市场保持活力和发展势头。这些专业公司利用尖端技术开发独特的解决方案，以解决特定的研究问题，从而在更广泛的生物技术设备市场中开闢出利润丰厚的细分领域。例如，2025年12月，全球生命科学工具、试剂和诊断产品供应商Biotechne宣布扩大其下一代Rheo™系统（采用Simple Western™技术）的供应范围并开始首批出货。

同样，2025年12月，牛津仪器公司重点发布了Imaris 11，这是其业界领先的3D/4D显微镜影像视觉化和分析软体的最新一代产品。此次软体升级增强了研究人员处理复杂生物成像数据的能力，透过更先进的可视化和分析工具，能够提供更深入的洞察。此外，2025年10月，公认的桌上型器官晶片（OOC）解决方案领导者CNBio发布了其PhysioMimix® Core平台，旨在加速药物发现和开发。

核心成长驱动因子

在定序通量不断创新的推动下，生物技术设备市场目前正经历着深刻的变革，重塑着生物研究的速度和范围。定序技术的进步彻底改变了我们分析遗传物质的能力，其速度、精度和深度都达到了前所未有的水平，使科学家能够揭开复杂的生物学谜题，并加速基因组学、个性化医疗和分子诊断等多个领域的发现。这种技术能力的指数级成长不仅提高了研究效率，也拓展了生物技术设备在学术界和商业领域的潜在应用。

新机遇

未来生物技术设备市场的需求正迅速转向整合多组学平台和自动化工作流程。这些先进平台显着减少了人为干预，并将基因组学、蛋白质组学、代谢组学和转录组学等多种组学技术整合到系统中，从而对生物样本进行全面、高通量的分析。透过整合多层生物数据，这些平台能够深入洞察复杂的生物过程，加速研发进程，并提高药物开发和诊断的准确性。这些工作流程中对自动化的重视源于提高效率、减少错误和增强可重复性的需要——这对于满足现代生物技术研究日益增长的需求至关重要。

优化障碍

生技设备市场目前面临着与资本成本和资产估值相关的重大挑战，这些挑战对市场成长构成了显着的阻力。利率上升推高了借贷成本，使得企业更难取得用于购买新设备和扩大基础设施的融资。这种财务压力在预算有限且研发活动严重依赖外部资金的中小型生技公司中尤为突出。因此，这些公司在支出方面变得更加谨慎，并且越来越多地推迟或缩减对关键生物技术设备的投资。

目录

第一章：摘要整理：全球生技设备市场

第二章：研究方法与架构

  • 研究目标
  • 产品概述
  • 市场区隔
  • 质性研究
    • 一手和二手资料来源
  • 量化研究
    • 一手和二手资料来源
  • 按地区划分的一手调查受访者组成
  • 研究假设
  • 市场规模估算
  • 资料三角验证

第三章：全球生技设备市场概论

  • 产业价值链分析
    • 原料供应商
    • 製造商
    • 经销商
    • 终端用户
  • 行业展望
    • 全球研发支出
    • 全球生物技术中心（2025 年）
  • PESTLE 分析
  • 波特五力分析
    • 供应商议价能力
    • 买方议价能力
    • 替代品威胁
    • 新进入者威胁
    • 竞争强度
  • 市场成长与展望
    • 市场收入估计与预测（2020-2035 年）
    • 市场估计与预测（基于销售），2020-2035 年
    • 依产品类型划分的价格趋势分析
  • 市场吸引力分析
    • 依产品类型
    • 按地区
  • 可操作的洞见（分析师建议）

第四章：竞争格局概览

  • 市场集中度
  • 公司占有率分析（基于价值，2025 年）
  • 竞争格局分析与标竿分析

第五章：全球生技设备市场分析

  • 市场动态与趋势
    • 成长驱动因素
    • 限制因素
    • 机遇
    • 关键趋势
  • 市场规模及预测（2020-2035 年）
    • 依产品类型
      • 分析仪器
      • 聚合酶炼式反应 (PCR)
      • 光谱仪
      • 显微镜
      • 色谱仪
      • 流式细胞仪
      • 定序仪
      • 微阵列
      • 其他
      • 细胞培养设备
      • 培养系统
      • 培养箱
      • 冷冻保存设备
      • 生物安全设备
      • 移液器
      • 细胞分离设备
      • 离心机
      • 过滤系统
      • 磁激活细胞分离系统
      • 免疫分析设备
      • 临床化学分析仪
      • 其他
    • 依应用领域分类
      • 製药和生技公司
      • 医院和诊断实验室
      • 学术研究机构
      • 其他
    • 按地区

第六章：北美生技设备市场分析

第七章：欧洲生技设备市场分析

第八章：亚太生物技术设备市场分析

第九章：中东和非洲生物技术设备市场分析

第十章：南美洲生技设备市场分析

第十一章：公司简介

  • AngioDynamics
  • Alcon
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Illumina
  • Danaher
  • Merck KGaA
  • GE医疗集团
  • 沃特世公司
  • 赛多利斯股份公司
  • 爱本多股公司
  • 其他主要公司

第十二章：附录

简介目录
Product Code: AA01261631

The Biotechnology Instruments Market is currently experiencing robust growth, reflecting the expanding role of biotechnology in healthcare, research, and industrial applications. Valued at US$ 92.12 billion in 2025, the market is projected to reach a substantial valuation of US$ 141.70 billion by 2035. This anticipated growth corresponds to a compound annual growth rate (CAGR) of 4.4% during the forecast period from 2026 to 2035, indicating steady and sustained expansion over the coming decade. The increasing demand for advanced biotechnology instruments is a key factor driving this positive market trajectory, as these tools are essential for enabling cutting-edge research and development across multiple disciplines.

Several critical factors underpin this market growth. One major driver is the surge in research and development activities focused on personalized medicine, which tailors treatments based on individual genetic profiles. The expanding use of genomics and related technologies requires sophisticated instruments capable of high-throughput and precise analysis, fueling demand across the biotechnology instruments sector. Additionally, the rising prevalence of chronic diseases worldwide has heightened the need for improved diagnostic and therapeutic solutions, prompting increased investment in biotechnology research.

Noteworthy Market Developments

The biotechnology instruments market is characterized by significant consolidation at the top, with industry giants such as Thermo Fisher Scientific and Danaher Corporation commanding the lion's share of the market. These major players maintain their dominance through extensive and diverse product portfolios that span a wide range of life sciences applications. Their established global reach, robust research and development capabilities, and comprehensive service offerings have solidified their positions as market leaders.

Despite this concentration of power among the largest corporations, the market remains vibrant and dynamic due to the presence of specialized challengers who are driving disruptive innovation in targeted niches. These specialized companies are leveraging cutting-edge technologies to develop unique solutions that address specific research challenges, allowing them to carve out lucrative segments within the broader biotechnology instruments landscape. For instance, in December 2025, Bio-Techne Corporation, a global provider of life science tools, reagents, and diagnostic products, announced the expanded launch and first shipment of its next-generation Leo(TM) System, which is powered by Simple Western(TM) Technology.

Similarly, Oxford Instruments made headlines in December 2025 with the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualization and analysis software. This software upgrade delivers enhanced capabilities for researchers working with complex biological imaging data, enabling deeper insights through more sophisticated visualization and analysis tools. Additionally, in October 2025, CN Bio, a recognized leader in benchtop Organ-on-a-chip (OOC) solutions designed to accelerate drug discovery and development, launched its PhysioMimix(R) Core platform.

Core Growth Drivers

The biotechnology instruments market is currently undergoing a significant transformation, driven by relentless innovation in sequencing throughput that is reshaping the pace and scope of biological research. Advances in sequencing technology have revolutionized the ability to analyze genetic material with greater speed, accuracy, and depth than ever before, enabling scientists to unravel complex biological questions and accelerate discoveries across diverse disciplines such as genomics, personalized medicine, and molecular diagnostics. This surge in technological capability is not only enhancing research efficiency but also expanding the potential applications of biotechnology instruments in both academic and commercial settings.

Emerging Opportunity Trends

Future demand within the biotechnology instruments market is increasingly shifting toward integrated multi-omics platforms and automated workflows that significantly reduce the need for human intervention. These advanced platforms combine various omics technologies-such as genomics, proteomics, metabolomics, and transcriptomics-into unified systems that enable comprehensive, high-throughput analysis of biological samples. By integrating multiple layers of biological data, these platforms provide deeper insights into complex biological processes, accelerating research and improving the precision of drug development and diagnostics. The emphasis on automation within these workflows is driven by the need to enhance efficiency, reduce errors, and increase reproducibility, all of which are critical for meeting the growing demands of modern biotechnology research.

Barriers to Optimization

The biotechnology instruments market is currently confronting notable challenges related to capital costs and asset valuations, which are creating significant headwinds for growth. Elevated interest rates have increased the cost of borrowing, making it more expensive for companies to finance new equipment purchases or expand their infrastructure. This financial pressure is particularly pronounced for smaller biotechnology firms that typically operate with limited budgets and rely heavily on external funding to support their research and development activities. As a result, these firms are adopting a more cautious approach to spending, often delaying or scaling back investments in essential biotechnology instruments.

Detailed Market Segmentation

By Product, the analytical instruments segment holds a commanding and undisputed position, capturing a substantial revenue share of 65.3%. This dominant share underscores the critical importance of analytical instruments in the life sciences industry, where they serve as the operational heartbeat of research, development, and manufacturing processes. These instruments provide the foundational capabilities necessary for molecular characterization, enabling scientists to analyze the structure, composition, and behavior of biological molecules with precision and accuracy.

By End-use, the pharmaceutical and biotechnology companies segment stands out as the primary force driving the growth of the biotechnology instruments market, accounting for more than 55% of the total revenue generated in this sector. This dominance reflects the critical role these companies play in advancing research and development activities that rely heavily on sophisticated biotechnology instruments. Their substantial investment in cutting-edge tools and technologies is essential to support various stages of drug discovery, testing, and manufacturing, positioning this segment at the forefront of market demand.

Segment Breakdown

By Product

  • Analytical Instruments
  • Polymerase Chain Reaction
  • Spectroscopy
  • Microscopy
  • Chromatography
  • Flow Cytometry
  • Sequencing
  • Microarray
  • Others
  • Cell Culture Instruments
  • Culture Systems
  • Incubators
  • Cryostorage Equipment
  • Biosafety Equipment
  • Pipetting Instruments
  • Cell Separation Instruments
  • Centrifuge
  • Filtration Systems
  • Magnetic-activated Cell Separator Systems
  • Immunoassay Instruments
  • Clinical Chemistry Analyzers
  • Others

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

By Region

  • North America
  • The US
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia and New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America continues to be the undisputed epicenter of demand in the global biotechnology instruments market, a position largely driven by the region's extensive pharmaceutical infrastructure and significant government funding. This dominance is reflected in the substantial physical presence of major industry players across the continent, particularly in the United States. The country remains the primary engine powering the market, supported by a robust ecosystem where large pharmaceutical companies, often referred to as "Big Pharma," operate with unparalleled financial resources.
  • Beyond the considerable corporate expenditures, the North American biotechnology instruments market also benefits from a revitalized investment climate that encourages rapid adoption of new technologies. Government initiatives, grants, and public-private partnerships contribute to an environment conducive to innovation and growth. This supportive ecosystem enables companies to quickly integrate advanced instruments into their workflows, accelerating scientific discovery and commercial applications.

Leading Market Participants

  • AngioDynamics
  • Alcon
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Illumina
  • Danaher
  • Merck KGaA
  • GE Healthcare
  • Waters Corporation
  • Sartorius AG
  • Eppendorf AG
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Biotechnology Instruments Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Biotechnology Instruments Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers
    • 3.1.2. Manufacturers
    • 3.1.3. Distributors
    • 3.1.4. End Consumers
  • 3.2. Industry Outlook
    • 3.2.1. Global R&D Expenditure
    • 3.2.2. Top Biotechnology Hubs in the World, 2025
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Market Volume Estimates and Forecast (Units), 2020-2035
    • 3.5.3. Price Trend Analysis, By Product Type
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. By Product Type
    • 3.6.2. By Region
  • 3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

  • 4.1. Market Concentration Rate
  • 4.2. Company Market Share Analysis (Value %), 2025
  • 4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Biotechnology Instruments Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Analytical Instruments
          • 5.2.1.1.1.1. Polymerase Chain Reaction
          • 5.2.1.1.1.2. Spectroscopy
          • 5.2.1.1.1.3. Microscopy
          • 5.2.1.1.1.4. Chromatography
          • 5.2.1.1.1.5. Flow Cytometry
          • 5.2.1.1.1.6. Sequencing
          • 5.2.1.1.1.7. Microarray
          • 5.2.1.1.1.8. Others
        • 5.2.1.1.2. Cell Culture Instruments
          • 5.2.1.1.2.1. Culture Systems
          • 5.2.1.1.2.2. Incubators
          • 5.2.1.1.2.3. Cryostorage Equipment
          • 5.2.1.1.2.4. Biosafety Equipment
          • 5.2.1.1.2.5. Pipetting Instruments
        • 5.2.1.1.3. Cell Separation Instruments
          • 5.2.1.1.3.1. Centrifuge
          • 5.2.1.1.3.2. Filtration Systems
          • 5.2.1.1.3.3. Magnetic-activated Cell Separator Systems
        • 5.2.1.1.4. Immunoassay Instruments
        • 5.2.1.1.5. Clinical Chemistry Analyzers
        • 5.2.1.1.6. Others
    • 5.2.2. By End-Use
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Pharmaceutical & Biotechnology Companies
        • 5.2.2.1.2. Hospitals & Diagnostic Laboratories
        • 5.2.2.1.3. Academic & Research Institutes
        • 5.2.2.1.4. Others
    • 5.2.3. By Region
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. North America
          • 5.2.3.1.1.1. The U.S.
          • 5.2.3.1.1.2. Canada
          • 5.2.3.1.1.3. Mexico
        • 5.2.3.1.2. Europe
          • 5.2.3.1.2.1. Western Europe
            • 5.2.3.1.2.1.1. The UK
            • 5.2.3.1.2.1.2. Germany
            • 5.2.3.1.2.1.3. France
            • 5.2.3.1.2.1.4. Italy
            • 5.2.3.1.2.1.5. Spain
            • 5.2.3.1.2.1.6. Rest of Western Europe
          • 5.2.3.1.2.2. Eastern Europe
            • 5.2.3.1.2.2.1. Poland
            • 5.2.3.1.2.2.2. Russia
            • 5.2.3.1.2.2.3. Rest of Eastern Europe
        • 5.2.3.1.3. Asia Pacific
          • 5.2.3.1.3.1. China
          • 5.2.3.1.3.2. India
          • 5.2.3.1.3.3. Japan
          • 5.2.3.1.3.4. South Korea
          • 5.2.3.1.3.5. Australia & New Zealand
          • 5.2.3.1.3.6. ASEAN
              • 5.2.3.1.3.6.1.1. Indonesia
              • 5.2.3.1.3.6.1.2. Malaysia
              • 5.2.3.1.3.6.1.3. Thailand
              • 5.2.3.1.3.6.1.4. Singapore
              • 5.2.3.1.3.6.1.5. Rest of ASEAN
          • 5.2.3.1.3.7. Rest of Asia Pacific
        • 5.2.3.1.4. Middle East & Africa
          • 5.2.3.1.4.1. UAE
          • 5.2.3.1.4.2. Saudi Arabia
          • 5.2.3.1.4.3. South Africa
          • 5.2.3.1.4.4. Rest of MEA
        • 5.2.3.1.5. South America
          • 5.2.3.1.5.1. Argentina
          • 5.2.3.1.5.2. Brazil
          • 5.2.3.1.5.3. Rest of South America

Chapter 6. North America Biotechnology Instruments Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 6.2.1. By Product Type
    • 6.2.2. By End-Use
    • 6.2.3. By Country

Chapter 7. Europe Biotechnology Instruments Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 7.2.1. By Product Type
    • 7.2.2. By End-Use
    • 7.2.3. By Country

Chapter 8. Asia Pacific Biotechnology Instruments Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 8.2.1. By Product Type
    • 8.2.2. By End-Use
    • 8.2.3. By Country

Chapter 9. Middle East & Africa Biotechnology Instruments Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 9.2.1. By Product Type
    • 9.2.2. By End-Use
    • 9.2.3. By Country

Chapter 10. South America Biotechnology Instruments Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn & Units)
    • 10.2.1. By Product Type
    • 10.2.2. By End-Use
    • 10.2.3. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. AngioDynamics
  • 11.2. Alcon
  • 11.3. Thermo Fisher Scientific
  • 11.4. Agilent Technologies
  • 11.5. Bio-Rad Laboratories
  • 11.6. PerkinElmer
  • 11.7. Illumina
  • 11.8. Danaher
  • 11.9. Merck KGaA
  • 11.10. GE Healthcare
  • 11.11. Waters Corporation
  • 11.12. Sartorius AG
  • 11.13. Eppendorf AG
  • 11.14. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Leather Types
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators